# Does Vitamin D Improves Sustained Virologic Response (SVR) in Genotype 2,3 Chronic Hepatitis C Patients?

> **NCT01146626** · NA · UNKNOWN · sponsor: **Ziv Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Peg+ Vitamin D+ Ribavirine
- **DRUG:** Peg+ Ribavirine

## Key facts

- **NCT ID:** NCT01146626
- **Lead sponsor:** Ziv Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-08
- **Primary completion:** 2012-02
- **Final completion:** 2012-05
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2011-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01146626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01146626, "Does Vitamin D Improves Sustained Virologic Response (SVR) in Genotype 2,3 Chronic Hepatitis C Patients?". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01146626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*